Medtronic (MDT) ended the recent trading session at $82.90, demonstrating a +0.44% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.81%.

Medtronic plc (NYSE:MDT – Get Free Report) was the target of unusually large options trading on Friday. Traders acquired ...

Underscoring the massive scale of America's medical debt problem, a nonprofit has struck a deal to pay off old medical bills ...

Explore the importance of Multidisciplinary Tumour Boards in comprehensive cancer care for personalized treatment and improved outcomes.

The FDA finalized a rule to oversee lab-developed tests as if they were medical devices, prompting lawsuits. Opponents said ...

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $87.00. The ...

Medtronic (MDT) shares snapped seven straight days of losses as the stock closed xx% higher, at $xx on Thursday. The medical device company lost more than 4% in ...

Medtronic’s diverse portfolio faces financial growth concerns. Learn why MDT stock is a HOLD, offering stability but limited growth in the short term.

That makes my official name Brett Sears, PT, MS, Cert. MDT. (Cert. MDT stands for "Certified in Mechanical Diagnosis and Therapy.") Some physical therapists sign their notes and other documents with ...

MDT stock is currently trading at a discount compared to the Medical Products industry. Its forward 12-month P/E of 15.56X is lower than the industry’s 21.78X at this moment. The stock also ...